AzTrials
AzTrials

White Spot LesionsPhase 4RINCT06696105

Assessing the Effects of Resin Infiltration and Resin Modified Glass Ionomer on the Color Changes of White Spot Lesions in a Clinical and Laboratory Setting

A Phase 4 study testing Resin infiltration and Vanish XT varnish (resin modified glass ionomer restoration) in people with White Spot Lesions and White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by King Abdulaziz University at 2 sites in Saudi Arabia.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to assess the efficacy of "Icon® resin infiltration" and "VanishTM XT varnish" in restoring the appearance of white spot lesions WSLs in healthy children affected with anterior white spot lesions. Read more about this study

Who is it for?
Ages 6 to 18 yearsHealthy volunteers can take part
What is being tested?
Resin infiltration and Vanish XT varnish (resin modified glass ionomer restoration)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesSaudi Arabia
Study dates
20 Aug 2024to 30 Dec 2025
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Healthy children
  • Presence of maxillary permanent anterior teeth with white spot lesions
  • Vital pulp in the anterior teeth.

Who cannot join

  • Any systemic or local conditions not permitting intervention
  • Unwillingness to participate in the study
  • Teeth with periodontal diseases, dental caries, direct or indirect restorations, yellow-brownish opacities with post eruptive enamel breakdown.

Trial locations and contacts

2 sites in 1 country.

Saudi Arabia2 sites
  • King Abdulaziz University

    Jeddah, Saudi Arabia

  • King Abdulaziz University

    Jeddah, 23514

Other trials in Saudi Arabia

About this study

Official title: Clinical and Laboratory Evaluation of Icon® Resin Infiltration and Vanish™ XT Varnish, on Color Changes of White Spot Lesions

The goal of this clinical trial is to assess the efficacy of "Icon® resin infiltration" and "VanishTM XT varnish" in restoring the appearance of white spot lesions WSLs in healthy children affected with anterior white spot lesions. The main questions it aims to answer are:

1- Are Icon resin infiltration (RI) and Vanish™ XT varnish comparable in restoring esthetics of white spot lesions? Researchers will compare Resin infiltration to vanish xt varnish to see if they are effective in masking white spot lesions

Read more

Participants will:

  • Have their white spot lesions treated in the dental clinic by the intervention methods
  • Visit the clinic after 1 month, 3 months and 6 months to assess the restorations objectively and subjectively
Read the detailed description

Aim

  1. Clinically assess the efficacy of "Icon® resin infiltration" and "VanishTM XT varnish" in restoring the appearance of WSLs
  2. Assess patients/parents' satisfaction after "Icon® resin infiltration" and VanishTM XT varnish" application.
  3. Evaluate the changes in lesion size by using cross-polarization photography. Materials and Methods The study will be carried out in the "Department of Pediatric Dentistry, Faculty of Dentistry, King Abdulaziz University (KAU)", after approval from the Research Ethics Committee.

Study design A randomized, controlled trial comparing the application of "Icon® resin infiltration" and "VanishTM XT varnish" in parallel groups with a 1:1 allocation ratio. Also, an experimental in vitro study will be conducted.

Clinical trial (Color measurement) Participants, eligibility criteria, and settings A convenient sample of participants attending "King Abdulaziz University Dental Hospital" "KAUDH" will be recruited with WSLs affecting at least one of the labial surfaces of their permanent anterior teeth.

WSLs will be objectively screened Using "DIAGNOdent®" which will quantitively evaluate the loss of the associated fluorescence of WSLs (Q) as well as sound enamel surrounding lesion. The "DIAGNOdent®" device employs blue laser light to illuminate the teeth. The dentin of a tooth comprises fluorophores, which exhibit green fluorescence upon exposure to blue laser light. The presence of a WSL will appear as a dark region surrounded by a green reflective hue, which is observed as a reduction in fluorescence. WSL could easily be overlooked with the absence of "DIAGNOdent®". Only WSLs (Q) scores of 2-9 will be included.

Additionally, WSLs will be subjectively be screened for WSLs using "Enamel Decalcification Index (EDI) by Banks and Richmond" ; only mild and moderate lesions will be considered (level 1 and level 2).

Description of the "EDI by Banks and Richmond" to measure the intensity of White Spot Lesions:

Level 0 = tooth surface without decalcification. Level 1 = clinically visible decalcification of \<50% of the examined surface.

Level 2 = moderate to grave decalcification of \> 50% of the examined surface.

Level 3 = decalcification on the entire examined surface or cavity, cracking the surface.

As for MIH lesions, criteria of selection will be established according to the European Academy of Pediatric Dentistry (EAPD) policy document. Any lesion with demarcated enamel opacities without a breakdown of the enamel, and induced sensitivity to external stimuli e.g. air/water but not brushing and mild aesthetic concerns on discoloration will be included in the study.

Oral hygiene status The patient's oral hygiene status will be carefully assessed via "Oral Hygiene Index scores by Green and Vermilion" before and during the study period.

Inclusion criteria Exclusion criteria Healthy children aged 6-18 years Any systemic or local conditions not permitting intervention The presence of maxillary permanent anterior teeth. Unwillingness to participate in the study

The finding of a minimum of two white spot lesions (WSLs) on the labial surfaces of maxillary anterior teeth Teeth with periodontal diseases, dental caries, direct or indirect restorations Vital pulp in the anterior teeth. Yellow-brownish opacities with post eruptive enamel breakdown

Patients' enrollment Informed consent forms will be obtained from the parents/guardians for the child's participation in the research.

Sample size calculation The sample size for the clinical trial was determined using "G power software". A significance level of 0.05 and a power of 85% was used as a base for calculations. The outcome will be the variance in color as well as the fluorescence values between treatment groups over a period of three to six months. It is estimated that 88 WSL (44 WSL in each arm), would be adequate.

Randomization In order to achieve even allocation of intervention modalities, computer-generated software available at www.randomization.com will be utilized. The program will employ a block allocation sequence consisting of the following patterns: "AABB, ABBA, BBAA, and BAAB." Group A- will include "icon® resin infiltration", Group B will include "Vanish™ XT varnish".

Allocation concealment and blinding of participants The patients will be blinded to the intervention procedures. The implementation of additional blinding measures will not be feasible due to the variations in material application procedures employed by the intervention approaches. Concealment of the boxes of the material will be done to ensure patients blinding. The same clinician will perform all the procedures.

Intervention methods

Group A: "Icon® resin infiltration" (n=44 teeth):

First, "Icon® Etch, DMG" will be spread for 2 minutes on the tooth affected with WSLs. Following this, water will be used to rinse, then air blowing. Afterwards, the application of "Icon® Dry, DMG" will be done for 30 seconds, followed by air blowing. The "Icon® Infiltrant, DMG" will be spread with the provided sponge applicator and left for three minutes to allow infiltration, then it will be followed by light curing for about sixty seconds.

Group B: "Vanish™ XT varnish" (n=44 teeth):

First, "37% orthophosphoric acid gel" will be applied on the WSL for 15 seconds. Then the paste and liquid components will be mixed on a paper pad for fifteen seconds via an agate spatula, then it will be spread on the WSLs. The material will then be lighted cured for twenty seconds.

Color measurement Both the treatment techniques will be evaluated using the "VITA Easyshade® advance spectrophotometer" before intervention as a baseline reading (T0), then right after intervention (T1), then three months later (T2), then six months later (T3). Photographs will be recorded at every interval. At (T0), the mapping of the dimensions and location of WSL will be done to assess the size and location of the WSLs to ensure an accurate reading.

Size determination using cross-polarisation photography A cross-polarisation filter suitable for our camera (Marumi, Japan) will be used before obtaining the intraoral photographs to minimize light reflection and glare and to be able to observe the lesion borders more clearly. Using photo retractors, intraoral photographs of the treatment and control groups will be obtained before; immediately after; and 1, 3 months after the application of the intervention methods. Next, these images will be analyzed using Image J (1.31o, National Institutes of Health, Bethesda, MD, USA) software, and the lesion areas of the teeth in the treatment group will be measured in mm. The differences in the measurements will be compared with each other at every interval to assess the size of the lesion.

Questionnaire of patients/parents' satisfaction after "Icon resin infiltration" and "Vanish™ XT varnish" application Questionnaires filled out by patients/parents assessing the comfort, complexity, time, and difficulties during the implementation of the intervention strategies. The first section of the questionnaire pertains to the child's demographic information, specifically their name, age and gender. The second section of the questionnaire includes 12 multiple choice questions about the dental restoration's over-all satisfaction, longevity, sensitivity, color, texture and associated defects.

Being tested
Resin infiltration, Vanish XT varnish (resin modified glass ionomer restoration)
Keywords
"camouflage", "prevention", white spot lesion", "remineralization"
Medical subject headings
Dental Enamel Hypomineralization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resin infiltrationDrug

    Also called RI

    "Icon® resin infiltration (DMG America, Englewood, NJ, US)" technique utilizes light-cured hydrophilic and low viscosity resins that can permeate WSL subsurface micropores. Resin modified glass ionomer cement includes Fluoroaluminosilicate glass, which facilitates the interaction of fluoride with the enamel surface resulting in an instant release . Concurrently, the predominant glass matrix serves as source of fluoride for the purpose of continuous release, hypothesized to facilitate remineralization.

  • Vanish XT varnish (resin modified glass ionomer restoration)Drug

    Also called Vanish XT varnish

    Resin modified glass ionomer cement includes Fluoroaluminosilicate glass, which facilitates the interaction of fluoride with the enamel surface resulting in an instant release. Concurrently, the predominant glass matrix serves as source of fluoride for the purpose of continuous release, hypothesized to facilitate remineralization.

Study groups in NCT06696105
Study groupRoleWhat they receive
Resin infiltration armExperimentalresin infiltration will be applied on white spot lesion of anterior teeth
vanish xt varnish armExperimentalvanish xt will be applied on white spot lesion of anterior teeth

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. color measurement

    The variance in the value of colors that are observed between two cohorts undergoing therapy, using vita shade spectrophotometer over a six-month period.

    Measured: 6 months

Secondary outcomes (1)
  1. color stability

    The stability of the colors of the two intervention techniques using vita shade spectrophotometer.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2024
  2. Study start20 Aug 2024
  3. Primary completion30 Jun 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
the lesions will receive restorative minimally invasive treatment
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06696105
Sponsor's protocol ID
140-07-23
Acronym
RI
Status last verified
Nov 2024
First submitted
18 Nov 2024
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No: Data is a part of a thesis and will be published through the research team only

Publications

  • Al-Haj Ali SN, Alsulaim HN, Albarrak MI, Farah RI. Spectrophotometric comparison of color stability of microhybrid and nanocomposites following exposure to common soft drinks among adolescents: an in vitro study. Eur Arch Paediatr Dent. 2021 Aug;22(4):675-683. doi: 10.1007/s40368-021-00605-6. Epub 2021 Feb 10.

    PubMed 33566286
  • Wiewiora C, Armbruster P, Lallier T, Ballard R. Effectiveness of Vanish XT in Reducing the Development of White Spot Lesions: An In Vitro Study. Oral Health Prev Dent. 2018;16(4):345-350. doi: 10.3290/j.ohpd.a40938.

    PubMed 30175332
  • Kannan A, Padmanabhan S. Comparative evaluation of Icon(R) resin infiltration and Clinpro XT varnish on colour and fluorescence changes of white spot lesions: a randomized controlled trial. Prog Orthod. 2019 Jun 17;20(1):23. doi: 10.1186/s40510-019-0276-y.

    PubMed 31204437
  • Giray FE, Durhan MA, Haznedaroglu E, Durmus B, Kalyoncu IO, Tanboga I. Resin infiltration technique and fluoride varnish on white spot lesions in children: Preliminary findings of a randomized clinical trial. Niger J Clin Pract. 2018 Dec;21(12):1564-1569. doi: 10.4103/njcp.njcp_209_18.

    PubMed 30560818
  • Mehta A, Paramshivam G, Chugh VK, Singh S, Halkai S, Kumar S. Effect of light-curable fluoride varnish on enamel demineralization adjacent to orthodontic brackets: an in-vivo study. Am J Orthod Dentofacial Orthop. 2015 Nov;148(5):814-20. doi: 10.1016/j.ajodo.2015.05.022.

    PubMed 26522042

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Resin infiltration and Vanish XT varnish (resin modified glass ionomer restoration) in people with White Spot Lesions and White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by King Abdulaziz University at 2 sites in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

color measurement (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06696105, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in